Startseite Naturwissenschaften Crystal structure of diaqua-bis(1,10-phenanthroline κ2N,N′)nickel(II) trifluoroacetate- trifluoroacetic acid (1/1), C30H21F9N4NiO8
Artikel Open Access

Crystal structure of diaqua-bis(1,10-phenanthroline κ2N,N′)nickel(II) trifluoroacetate- trifluoroacetic acid (1/1), C30H21F9N4NiO8

  • Lan Zhang EMAIL logo , Qiang Wang , Wu-Xiu Ding und Hui-Min Hao
Veröffentlicht/Copyright: 18. Juni 2019

Abstract

C30H21F9N4NiO8, monoclinic, P21/c (no. 13), a = 10.0630(11) Å, b = 9.625(1) Å, c = 18.196(2) Å, β = 116.10(3)°, V = 1582.7(5) Å3, Z = 2, Rgt(F) = 0.0511, wRref(F2) = 0.1261, T = 293(2) K.

CCDC no.: 1878440

The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colorless block
Size:0.29 × 0.22 × 0.17 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.72 mm−1
Diffractometer, scan mode:Bruker D8 Venture, φ and ω-scans
θmax, completeness:25°, >99%
N(hkl)measured, N(hkl)unique, Rint:7825, 2789, 0.055
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 1773
N(param)refined:259
Programs:Bruker programs [1], SHELX [2], [3], OLEX2 [4], DIAMOND [5]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Ni10.0000000.57723(6)0.2500000.0480(3)
O1W0.1279(4)0.7328(3)0.2369(2)0.0606(8)
O10.1119(4)0.1083(4)0.3130(2)0.0885(10)
H1Aa0.0238860.1140200.2809800.133*
O20.0422(3)−0.0619(3)0.37090(18)0.0787(9)
O30.3863(3)0.6494(3)0.2445(2)0.0981(12)
N1−0.1107(4)0.4271(3)0.2840(2)0.0515(8)
N20.1397(3)0.5616(3)0.37401(19)0.0522(8)
F10.3736(3)−0.0366(4)0.4255(2)0.1435(14)
F20.2844(4)−0.0143(5)0.5081(2)0.1569(16)
F30.3297(3)0.1613(3)0.45731(19)0.1113(10)
F4a0.3993(18)0.9190(10)0.2599(16)0.165(6)
F5a0.6276(15)0.9073(11)0.3027(9)0.142(4)
H1WA0.084(4)0.800(4)0.210(2)0.053(13)*
H1WB0.223(7)0.720(5)0.242(3)0.14(2)*
F6a0.490(2)0.8949(14)0.1755(8)0.236(6)
C1−0.2357(5)0.3615(4)0.2387(3)0.0642(11)
H1−0.2872190.3865530.1839160.077*
C2−0.2940(6)0.2573(4)0.2685(4)0.0816(15)
H2−0.3819730.2132760.2343700.098*
C3−0.2208(6)0.2210(4)0.3480(4)0.0795(15)
H3−0.2582980.1509440.3687960.095*
C4−0.0880(5)0.2883(4)0.3999(3)0.0638(12)
C5−0.0384(5)0.3902(4)0.3635(3)0.0541(10)
C60.0966(5)0.4634(4)0.4123(3)0.0544(10)
C70.1772(5)0.4319(4)0.4957(3)0.0629(11)
C80.1214(6)0.3271(5)0.5298(3)0.0794(14)
H80.1731330.3056400.5850880.095*
C9−0.0034(7)0.2591(5)0.4844(4)0.0813(15)
H9−0.0358640.1905540.5086840.098*
C100.3063(6)0.5063(5)0.5395(3)0.0759(13)
H100.3631760.4881020.5948680.091*
C110.3497(5)0.6057(5)0.5016(3)0.0724(12)
H110.4355710.6566280.5307290.087*
C120.2643(5)0.6303(4)0.4189(3)0.0618(11)
H120.2955600.6980350.3934970.074*
C130.1280(5)0.0243(4)0.3693(3)0.0608(11)
C140.2773(5)0.0352(5)0.4412(3)0.0732(13)
C150.5000000.7027(6)0.2500000.0568(15)
C160.5000000.8594(7)0.2500000.088(2)
  1. aOccupancy: 0.5.

Source of materials

All reagents were of analytical grade and used as purchased without further purification. A mixture of nickel oxide (0.0027 mmol, 0.2049 g), trifluoroacetic acid (HTFA) (0.0054 mol, 0.6140 g) and H2O (60 mL) were added to the round bottom flask in turn. After refluxing for 2 h, 1,10-phenanthroline (Phen) (0.0014 mmol, 0.2681 g) was added. Continue heating reflux for 6 h, and then the solution was cooled, filtered and recrystallized. Green block-shaped crystals of the title compound were obtained after 3 days.

Experimental details

Absorption corrections were applied by using multi-scan program [1]. All of the non-hydrogen atoms were refined anisotropically. Hydrogen atoms bound to carbon atoms were generated geometrically and refined isotropically with a riding model except for those bound to water molecules which were located from the difference Fourier synthesis. Significantly larger ellipsoids for the fluorine atoms of the TFA anions point to a positional disorder.

Comment

The synthesis and applications of fluorinated compounds have recently received significant attention due to their excellent performance in pharmaceuticals, agricultural chemistry and materials science [6], [7], [8], [9], [10], [11], [12]. Trifluoromethyl is widely used in the design of drug molecular synthesis because it can significantly improve the metabolic stability, lipophilic property and bioavailability of drug molecules [13], [14], [15]. Particularly, the F atom of trifluoroacetic acid can form weak F⋯F and F⋯H interactions, which can reinforce the crystal packing and construct more flexible structures. 1,10-Phenanthroline is a multidentate ligand with a rigid structure, which may adopt diverse binding modes to construct novel functional complexes [16]. However, as far as we know, trifluoroacetic coordination compounds, especially compounds with strong hydrogen bonding interactions between transition metal complexes and guest molecules are rarely reported.

The basic structural unit of the title compound [Ni(Phen)2(H2O)2] (TFA)2⋅HTFA consists of one diaqua-bis(1,10-phenanthroline) with nickel [Ni(Phen)2(H2O)2]2+ cation, two trifluoroacetate anions and one independent trifluoroacetic acid molecule (see the figure). The central Ni ion exhibits a distorted octahedral coordination, defined by four nitrogen atoms from two different Phen ligands and two oxygen atoms from two individual water molecules. The HTFA molecule and TFA anions remain uncoordinated. The Ni—O bond length is 2.055(3) Å, and two Ni—N bond lengths are 2.073(3) and 2.079(3) Å. The N—Ni—N bite angles are all 79.67(13)°. The angle of OW—Ni—OW is 86.48(18)°. The bond angles of OW—Ni—N are in the range of 91.13(12)° and 170.41(13)°. The fluorine atoms of the TFA anions of the HTFA molecule of the title compound are disordered over two positions. The water molecules in the structure of the title compound participate in the formation of intermolecular hydrogen bonds: (a) hydrogen bonds (O1W—H1WB⋯O3: 2.666(4) Å and 165(5)°) with TFA anions, which connect the mononuclear units to form a chain structure along the a axis; (b) hydrogen bonds (O1W—H1WA⋯O23: 2.780(4) Å and 170(4)°: − x, y + 1, − z + 1/2) link the uncoordinated HTFA molecule. Furthermore, there are intermolecular hydrogen bonds between adjacent HTFA molecules (O1—H1A⋯O11: 2.404(7) Å and 151.0°: −x, +y, 1/2 − z). The molecular structure and packing are stabilized by intermolecular O—H⋯O hydrogen bond interactions. Geometric parameters are within the expectations [17].

Award Identifier / Grant number: 51279073

Funding statement: This work was supported by the National Natural Science Foundation of China (no. 51279073), the Project of Science and Technology in Henan Province (no. 152102310108).

References

1. Bruker. SAINT. Bruker AXS Inc., Madison, WI, USA (2015).Suche in Google Scholar

2. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Suche in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

4. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Suche in Google Scholar

5. Brandenburg, K.: DIAMOND. Visual Crystal Structure Information System. Ver. 4.0. Crystal Impact, Bonn, Germany (2015).Suche in Google Scholar

6. Guo, S.; Cong, F.; Guo, R.; Wang, L.; Tang, P. P.: Asymmetric silver-catalysed intermolecular bromotrifl uoromethoxylation of alkenes with a new trifluoromethoxylation reagent. Nat. Chem. 9 (2017) 546–551.10.1038/nchem.2711Suche in Google Scholar PubMed

7. Berger, R.; Resnati, G.; Metrangolo, P.; Weber, E.; Hulliger, J.: Organic fluorine compounds: a great opportunity for enhanced materials properties. Chem. Soc. Rev. 40 (2011) 3496–3508.10.1039/c0cs00221fSuche in Google Scholar PubMed

8. Jian, F. F.; Zhao, P. S.; Zhang, L.; Zheng, J.: Synthesis, structure and quantum chemical calculations on p-trifluoromethylphenyl thioacid amide. J. Fluorine Chem. 127 (2006) 63–67.10.1016/j.jfluchem.2005.10.003Suche in Google Scholar

9. Tagaya, A.; Koike, K.; Koike, Y.; Okamoto, Y.: Effect of trifluoromethyl substituents on birefringence of polystyrene. Polym. Adv. Technol. 28 (2017) 994–999.10.1002/pat.3825Suche in Google Scholar

10. Nemes, A.; Mérész, E.; Jalsovszky, I.; Szabó, D.; Böcskei, Z.; Rábai, József.: Unusual reactivity of trifluoromethyl groups in meso-tetrakis(trifluoromethyl)porphyrin. J. Fluorine Chem. 203 (2017) 75–80.10.1016/j.jfluchem.2017.05.009Suche in Google Scholar

11. Gakh, A. A.; Shermolovich, Y.: Trifluoromethylated heterocycles. Curr. Top. Med. Chem. 14 (2014) 952–965.10.2174/1568026614666140202210424Suche in Google Scholar PubMed

12. Zhu, W.; Wang, J.; Wang, S. N.; Gu, Z. N.; Aceña, J. L.; Izawa, K.; Liu, H.; Soloshonok, V. A.: Recent advances in the trifluoromethylation methology and new CF3-containing drugs. J. Fluorine Chem. 167 (2014) 37–54.10.1016/j.jfluchem.2014.06.026Suche in Google Scholar

13. Isanbor, C.; O’Hagan, D.: Fluorine in medicinal chemistry: a review of anticancer agents. J. Fluorine Chem. 127 (2006) 303–319.10.1016/j.jfluchem.2006.01.011Suche in Google Scholar

14. Pinard, E.; Alanine, A.; Alberati, D.; Bender, M.; Borroni, E.; Bourdeaux, P.; Brom, V.; Burner, S.; Fischer, H.; Hainzl, D.; Halm, R.; Hauser, N.; Jolidon, S.; Lengyel, J.; Marty, H.; Meyer, T.; Moreau, J.; Mory, R.; Narquizian, R.; Nettekoven, M.; Norcross, R. D.; Puellmann, B.; Schmid, P.; Schmitt, S.; Stalder, H.; Wermuth, R.; Wettstein, J. G.; Zimmerli, D.: Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia. J. Med. Chem. 53 (2010) 4603–4614.10.1021/jm100210pSuche in Google Scholar PubMed

15. Feraldi-Xypolia, A.; Pardo, D. G.; Cossy, J.: Synthesis of α-(trifluoromethyl)pyridazine derivatives. Eur. J. Org. Chem. 27 (2018) 3541–3553.10.1002/ejoc.201701412Suche in Google Scholar

16. Kang, H. X.; Fu, Y. Q.; Ju, F. Y.; Li, G. L.; Li, X. L.; Liu, G. Z.: Syntheses, structures, and magnetic properties of two Mn(II) coordination polymers based on 4-fluorocinnamic acid and 1,10-phenanthroline. Russ. J. Coord. Chem. 44 (2018) 340–346.10.1134/S1070328418050020Suche in Google Scholar

17. Nikiforov, A. A.; Eremin, A. V.; Gurzhii, V. V.; Misharev, A. D.; Medvedskii, N. L.; Ponyaev, A. I.; Belyaev, A. N.: Syntheses and structural studies of the nickel(II) octahedral complexes Ni(N∩N) x L2 with nitrogen-containing and carboxylate ligands. Russ. J. Coord. Chem. 43 (2017) 269–277.10.1134/S1070328417050050Suche in Google Scholar

Received: 2019-01-16
Accepted: 2019-03-11
Published Online: 2019-06-18
Published in Print: 2019-09-25

©2019 Lan Zhang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Frontmatter
  2. Crystal structure of poly[diaqua-(μ8-1,1′:2′,1′′-terphenyl-3,3′′,4′,5′-tetracarboxylato-κ8O1:O2:O3:O4:O5:O6:O7:O8)dicopper(II)], C22H14Cu2O10
  3. Crystal structure of 2-((1H-benzo[d]imidazol-2-ylimino)methyl)-4,6-di-tert-butylphenol, C22H27N3O
  4. Crystal structure of (4-ethoxynaphthalen-1-yl)(furan-2-yl)methanone, C17H14O3
  5. Crystal structure of 1-nonylpyridazin-1-ium iodide, C13H23N2I
  6. Crystal structure of bis[diaqua(1,10-phenanthroline-κ2N, N′)-copper(II)]diphenylphosphopentamolybdate dihydrate, C36H38Cu2Mo5N4O27P2
  7. The crystal structure of tetrakis(imidazole)-copper(I) hexafluorophosphate, C12H16CuF6PN8
  8. The crystal structure of dimethyl ((3,5-di-tert-butyl-4-hydroxyphenyl)(phenyl)methyl)phosphonate, C23H33O4P
  9. Crystal structure of diaqua-bis(1,10-phenanthroline κ2N,N′)nickel(II) trifluoroacetate- trifluoroacetic acid (1/1), C30H21F9N4NiO8
  10. Crystal structure of 2-(naphthalen-2-yl)-1,8-naphthyridine, C18H12N2
  11. Synthesis and crystal structure of a new polymorph of diisopropylammonium trichloroacetate, C8H16Cl3NO2
  12. Crystal structure of dimethanol-bis(1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κN)-bis(thiocyanato-κN)cadmium(II) C34H34CdN12O2S2
  13. Crystal structure of ethyl 2,2-difluoro-2-(7-methoxy-2-oxo-2H-chromen-3-yl)acetate, C14H12F2O5
  14. The crystal structure of bis[μ2-(N,N-diethylcarbamodithioato-κSSS′)] bis[1′-(diphenylphosphino-κP)-1-cyanoferrocene]disilver(I), C56H56Ag2Fe2N4P2S4
  15. Crystal structure of bis(di-n-butylammonium) tetrachloridodiphenylstannate(IV), C28H50Cl4N2Sn
  16. The crystal structure of poly[(μ5-2-((5-bromo-3-formyl-2-hydroxybenzylidene)amino)benzenesulfonato-κ6O:O:O,O′:O′:O′′)sodium(I)], C13H9O4NSBrNa
  17. Crystal structure of catena-{poly[bis(O,O′-diethyldithiophosphato-S)-(μ2-1,2-bis(4-pyridylmethylene)hydrazine-N,N′)-zinc(II)] di-acetonitrile solvate}, {C20H30N4O4P2S4Zn ⋅ 2 C2H3N}n
  18. Halogen and hydrogen bonding in the layered crystal structure of 2-iodoanilinium triiodide, C6H7I4N
  19. Crystal structure of cyclohexane-1,4-diammonium 2-[(2-carboxylatophenyl)disulfanyl]benzoate — dimethylformamide — monohydrate (1/1/1), [C6H16N2][C14H8O4S2] ⋅ C3H7NO⋅H2O
  20. The synthesis and crystal structure of isobutyl 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-((trifluoromethyl)sulfinyl)-1H-pyrazole-3-carboxylate, C16H13Cl2F6N3O3S
  21. Isolation and crystal structure of bufotalinin — methanol (1/1), C25H34O7
  22. Crystal structure of benzylbis(1,3-diphenylpropane-1,3-dionato-κ2O,O′) chloridotin(IV), C37H29ClO4Sn
  23. Crystal structure of Bis{1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-methyl-imidazol)}diiodidocadmium(II), [Cd(C11H11N5)2I2], C22H22N10I2Cd
  24. Crystal structure of 4-isobutoxybenzaldehyde oxime, C11H15NO2
  25. The crystal structure of bis(acetato-κ1O)-bis(N′-hydroxypyrimidine-2-carboximidamide-κ2N,N′)manganese(II) — methanol (1/2), C14H18MnN8O6, 2(CH3OH)′
  26. Crystal structure of poly[bis(μ2-bis(4-(1H-imidazol-1-yl)phenyl)amine-κ2N:N′)-bis(nitrato-κO)cadmium(II)], C36H30CdN12O6
  27. Crystal structure and optical properties of 1,6-bis(methylthio)pyrene, C18H14S2
  28. The crystal structure of hexaquamagnesium(II) bis(3,4-dinitropyrazol-1-ide), C6H14MgN8O14
  29. Halogen bonds in the crystal structure of 4,3:5,4-terpyridine – 1,4-diiodotetrafluorobenzene (1/1), C21H11F4I2N3
  30. Crystal structure and photochromic properties of a novel photochromic perfluordiarylethene containing a triazole bridged pyridine group moiety, C24H18F6N4S2
  31. Crystal structure of bis[(μ3-oxido)-(μ2-(N,N-diisopropylthiocarbamoylthio) acetato-κ2O,O′)-((N,N-diisopropylthiocarbamoylthio)acetato-κO)-bis(di-4-methylbenzyl-tin(IV))], C100H136N4O10S8Sn4
  32. Crystal structure of dibromidobis(4-bromobenzyl)tin(IV), C14H12Br4Sn
  33. The crystal structure of (4Z)-2-[(E)-(1-ethyl-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene)methyl]-4-[(1-ethyl-3,3-dimethyl-3H-indolium-2-yl)methylidene]-3-oxocyclobut-1-en-1-olate, C30H32N2O2
  34. The crystal structure of (E)-3-(4-(dimethylamino)styryl)-5,5-dimethylcyclohex-2-en-1-one, C18H23NO
  35. Crystal structure of dihydrazinium 1H-pyrazole-3,5-dicarboxylate, C5H12N6O4
  36. Crystal structure of poly[μ2-1,4-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′)-(μ2-4-sulfidobenzoate-κ2O:S)cobalt(II)] dihydrate, C42H44Co2N8O7S2
  37. Crystal structure of 8-(3,4-dimethylbenzylidene)-6,10-dioxaspiro[4.5]decane-7,9-dione, C17H18O4
  38. Crystal structure of 4-(2-bromo-4-(6-morpholino-3-phenyl-3H-benzo[f]chromen-3-yl) cyclohexa-2,5-dien-1-yl)morpholine, C33H31BrN2O
  39. Synthesis and crystal structure of 2-((1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)methylene)-2,3-dihydro-1H-inden-1-one, C23H16N2OS
  40. Crystal structure of poly[(μ2-1,1′-(oxybis(4,1-phenylene)bis(1H-imidazole)-κ2N,N′)(μ2-1,3-benzenecarboxylato-κ3O,O′:O′′)zinc(II)] dihydrate, C26H22N4O7Zn
  41. Crystal structure of diaqua-bis(cinnamato-κ2O,O′)zinc(II), C18H18ZnO6
  42. Crystal structure of 2-(prop-2-yn-1-yloxy)-1-naphthaldehyde, C14H10O2
  43. Crystal structure and photochromic properties of 1-(2-methyl-5-phenyl-3-thienyl)-2-{2-methyl-5-[4-(9-fluorenone hydrazone)-phenyl]-3-thienyl}perfluorocyclopentene, C41H26F6N2S2
  44. Hydrothermal synthesis and crystal structure of cylo[tetraaqua-bis(μ2-1,4-bis(1H-benzo[d]imidazol-1-yl)but-2-ene-κ2N:N′)-bis(μ2-4-nitro-phthalate-κ2O,O′)dinickel(II)], C26H23N5O8Ni
  45. Crystal structure of 3-[methyl(phenyl)amino]-1-phenylthiourea, C14H15N3S
  46. Crystal structure of 1-(4-chlorophenyl)-3-[methyl(phenyl)amino]thiourea, C14H14ClN3S
  47. Crystal structure of 2-tert-butyl-1H-imidazo[4,5-b]pyridine, C10H13N3
  48. Crystal structure of 5-carboxy-2-(2-carboxyphenyl)-1H-imidazol-3-ium-4-carboxylate dihydrate, C12H8N2O6⋅2(H2O)
  49. The crystal structure of dichlorido-μ2-dichlorido-(η2-1,4-bis(4-vinylbenzyl)-1,4-diazabicyclo[2.2.2]octane-1,4-diium)dicopper(I), C24H30N2Cu2Cl4
  50. Crystal structure of 4-bromobenzyl (Z)-N-(adamantan-1-yl)morpholine-4-carbothioimidate, C22H29BrN2OS
  51. Crystal structure of (4S,4aS,6aR,6bR,12aS,12bR,14aS,14bR)-3,3,6a,6b,9,9,12a-heptamethyloctadecahydro-1H,3H-4,14b-ethanophenanthro[1,2-h]isochromene-1(6bH)-one, C30H48O2
  52. Crystal structure of 3,5-bis(trifluoromethyl)benzyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidate, C30H33F6N3S
  53. The crystal structure of 3-methoxyphenanthridin-6(5H)-one, C14H11NO2
  54. Crystal structure of 4-(5,5-difluoro-1,3,7,9-tetramethyl-3H,5H-5λ4-dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinin-10-yl)pyridin-1-ium tetraiodidoferrate(III), C18H19BF2FeI4N3
  55. Crystal structure of 2-(3-methoxyphenyl)-3-((phenylsulfonyl)methyl)imidazo[1,2-a]pyridine, C21H18N2O3S
  56. Crystal structure of [(2-(2-chlorophenyl)-5-ethyl-1,3-dioxane-5-carboxylato-κ2O,O′) (5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II) perchlorate, C29H50Cl2N4NiO8
  57. Crystal structure of (Z)-6-(dimethylamino)-3,3-bis(4-(dimethylamino)phenyl)-2-(2-(quinoxalin-2-ylmethylene)hydrazinyl)-2,3-dihydroinden-1-one, C35H35N7O
  58. 5-Methyl-N′-[5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazole-4-carbonyl]-1-(4-methylphenyl)-1H-1,2,3-triazole-4-carbohydrazide, C22H22N8O2
  59. Crystal structure of 2,3-dichloro-6-methoxyquinoxaline, C9H6Cl2N2O
  60. Synthesis and crystal structure of 7-chloro-2-(ethylsulfinyl)-6-fluoro-3-(1H-pyrazole-1-yl)-4H-thiochromen-4-one, C13H10FN3OS2
  61. Crystal structure of 4-ethylpiperazine-1-carbothioic dithioperoxyanhydride, C14H26N4S4
  62. Crystal structure of 2-(2-(6-methylpyridin-2-yl)naphthalen-1-yl)pyrimidine, C20H15N3
  63. The crystal structure of N′-((1E,2E)-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbut-2-en-1-ylidene)-3-methylbenzohydrazide, C23H22N2O4
  64. Crystal structure of catena-poly[(μ2-isophthalato-κ2O:O′)-(2,5-di(pyrazin-2-yl)-4,4′-bipyridine-κ3N,N′,N′′)zinc(II)] — water (2/5), C26H21N6O6.5Zn
  65. Crystal structure of (3E,5E)-3,5-bis(3-nitrobenzylidene)-1-((4-(trifluoromethyl)phenyl)sulfonyl)piperidin-4-one — dichloromethane (2/1), C53H38Cl2F6N6O14S2
  66. Crystal structure of (μ2-oxido)-bis(N,N′-o-phenylenebis(salicylideneiminato))diiron(III) — N,N′-dimethylformamide, C47H43Fe2N4O9
  67. Crystal structure of N1,N3-bis(2-hydroxyethyl)-N1, N1,N3,N3-tetramethylpropane-1,3-diaminium dibromide, C11H28Br2N2O2
  68. Crystal structure of (E)-N-(4-chlorophenyl)-1-(pyridin-2-yl)methanimine, C12H9ClN2
  69. Crystal structure of 8-bromo-6-oxo-2-phenyl-6H-pyrrolo[3,2,1-ij]quinoline-5-carbaldehyde, C18H11BrNO2
  70. Crystal structure of 1,4-bis(2-azidoethyl)piperazine-1,4-diium dichloride trihydrate, C8H18N8Cl2 ⋅ 3 H2O
  71. Crystal structure of (E)-4-bromo-N-(pyridin-2-ylmethylene)aniline, C12H9BrN2
  72. Crystal structure of bis[(2-(3-bromophenyl)-5-methyl-1,3-dioxane-5-carboxylato-κ-O)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II), C40H60Br2N4NiO8
  73. The crystal structure of (1E,2E)-2-methyl-4-((7-oxo-7H-furo[3,2-g]chromen-9-yl)oxy)but-2-enal O-isonicotinoyl oxime–trichloromethane (3/1), C67H49Cl3N6O18
  74. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-methyl-1H-imidazol-3-ium hexafluoridophosphate(V), C8H13F6N2O2P
  75. Crystal structure of bis[(2-(2-bromophenyl)-5-ethyl-1,3-dioxane-5-carboxylato-κO)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II) hemihydrate C42H65Br2N4NiO8.5
  76. The crystal structure of N-(7-(4-fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbonothioyl)benzamide, C28H23F2N3OS
  77. The crystal structure of N1,N4-bis(pyridin-3-yl)cyclohexane-1,4-dicarboxamide, C18H20N4O2
  78. Crystal structure of (E)-2-(3,6-bis(ethylamino)-2,7-dimethyl-9H-xanthen-9-yl)-N′-((6-methylpyridin-2-yl)methylene)benzohydrazide – methanol (1/1), C34H37N5O3
  79. Crystal structure of 2-oxo-1-(pyrimidin-5-ylmethyl)-3-(3-(trifluoromethyl)phenyl)-1,2-dihydro-5l4-pyrido[1,2-a]pyrimidin-4-olate, C20H13F3N4O2
  80. Crystal structure of poly[(μ3-9H-carbazole-3,6-dicarboxylato-κ3O1: O2: O3)(μ2-4-(pyridin-4-yl)pyridine-κ2N1:N1′)zinc(II)], C19H11N2O4Zn
  81. Crystal structure of (E)-N′-((1,8-dihydropyren-1-yl)-methylene)picolinohydrazide, C23H15N3O
  82. Crystal structure of catena-poly{[μ2-1,2-bis(diphenylphosphino)ethane]dichloridocadmium(II)}, C26H24CdCl2P2
  83. Crystal structure of the 1:2 co-crystal between N,N′-bis(4-pyridylmethyl)oxalamide and acetic acid as a dihydrate, C14H14N4O2⋅2 C2H4O2⋅2 H2O
  84. Crystal structure of the co-crystal N,N′-bis(3-pyridylmethyl)oxalamide acetic acid (1/2), C14H14N4O2⋅2C2H4O2
  85. Crystal structure of the co-crystal N,N′-bis(4-pyridylmethyl)oxalamide and 2,3,5,6-tetrafluoro-1,4-di-iodobenzene (1/1), C14H14N4O2⋅C6F4I2
  86. Crystal structure of the co-crystal 4-[(4-carboxyphenyl)disulfanyl]benzoic acid–(1E,4E)-1-N,4-N-bis(pyridin-4-ylmethylidene)cyclohexane-1,4-diamine (1/1), C14H10O4S2⋅C18H20N4
  87. Crystal structure of hexacarbonyl-bis(μ2-di-n-propyldithiocarbamato-κ3S,S′:S3S:S:S′)-di-rhenium(I), C20H28N2O6Re2S4
  88. Crystal structure of fac-tricarbonyl-morpholine-κN-(morpholinocarbamodithioato-κ2S,S′)rhenium(I), C12H17N2O5ReS2
Heruntergeladen am 5.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0052/html
Button zum nach oben scrollen